Segall Bryant & Hamill’s Boston Scientific BSX Stock Holding History

Segall Bryant & Hamill’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-67,359	Closed	-$4.23M	–	598
2026 Q1	$4.23M	Sell	67,359 -8,164	-11%	-$653K	0.06%	327
2025 Q4	$7.2M	Sell	75,523 -165,257	-69%	-$16.2M	0.1%	271
2025 Q3	$23.5M	Buy	240,780 +146,683	+156%	+$15.2M	0.31%	105
2025 Q2	$10.1M	Buy	94,097 +12,477	+15%	+$1.26M	0.14%	228
2025 Q1	$8.23M	Buy	+81,620	New	+$8.22M	0.13%	245
2016 Q4	–	Sell	-10,569	Closed	-$252K	–	542
2016 Q3	$252K	Buy	10,569 +33	+0.3%	+$787	0.01%	495
2016 Q2	$246K	Buy	+10,536	New	+$228K	0.01%	500

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Segall Bryant & Hamill's BSX Position: Q2 2026 in Review

Segall Bryant & Hamill sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 67,359 shares — an estimated $4.23M sold.

Segall Bryant & Hamill first reported a position in BSX in Q2 2016 and held it in 7 quarters. The position peaked at $23.5M in Q3 2025. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Segall Bryant & Hamill reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Segall Bryant & Hamill sold 67,359 Boston Scientific shares in Q2 2026, an estimated $4.23M.
Segall Bryant & Hamill first reported a position in Boston Scientific in Q2 2016 and held it in 7 quarters.
Segall Bryant & Hamill's Boston Scientific position peaked at $23.5M in Q3 2025.
1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.